Education
About Us
Working with TipRanks
Follow Us
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
Total Valuation
Ensysce Biosciences has a market cap or net worth of $4.23M. The enterprise value is $7.49M.
Market Cap$4.23M
Enterprise Value$7.49M
Share Statistics
Ensysce Biosciences has 1,644,728 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,644,728
Owned by Insiders―
Owned by Institutions8.12%
Financial Efficiency
Ensysce Biosciences’s return on equity (ROE) is -2.15 and return on invested capital (ROIC) is -195.69%.
Return on Equity (ROE)-2.15
Return on Assets (ROA)-1.43M
Return on Invested Capital (ROIC)-195.69%
Return on Capital Employed (ROCE)3.05
Revenue Per Employee0.00
Profits Per Employee-1.14T
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ensysce Biosciences is >-0.01. Ensysce Biosciences’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Ensysce Biosciences had revenue of 0.00 and earned -7.99T in profits. Earnings per share was -4.57M.
Revenue0.00
Gross Profit0.00
Operating Income-6.73T
Pretax Income-7.99T
Net Income-7.99T
EBITDA-6.73T
Earnings Per Share (EPS)-4.57M
Cash Flow
In the last 12 months, operating cash flow was -7.50M and capital expenditures 0.00, giving a free cash flow of -7.50M billion.
Operating Cash Flow-7.50M
Free Cash Flow-7.50M
Free Cash Flow per Share-4.56
Dividends & Yields
Ensysce Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change-74.74%
50-Day Moving Average3.34
200-Day Moving Average5.73
Relative Strength Index (RSI)40.15
Average Volume (3m)3.32M
Important Dates
Ensysce Biosciences upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateMar 10, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Ensysce Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 8.13%
Current Ratio2.42
Quick Ratio2.42
Debt to Market Cap21.22K
Net Debt to EBITDA-0.04
Interest Coverage Ratio5.22
Taxes
In the past 12 months, Ensysce Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Ensysce Biosciences EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.04.
EV to Sales0.00
EV to EBITDA-0.04
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Ensysce Biosciences has $3.50M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$3.20M billion.
Cash & Marketable Securities$3.50M
Total Debt$0.00
Net Cash-$3.20M
Net Cash Per Share-$1.95
Tangible Book Value Per Share-$5.78K
Margins
Gross margin is -94.30%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-94.30%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Ensysce Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast133.58%
EPS Growth Forecast82.60%